Navigation Links
THE PLANNING SHOP international Announces Oncology Business Unit

PHILADELPHIA and LONDON, June 30 /PRNewswire/ -- THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area. This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.

Oncology is a complex, fast moving therapeutic area.  Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer.  Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products.  The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands. Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.

"TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit," said Kim Hughes, Managing Director, TPSi London.  "Her joining TPSi represents the merger of deep oncology therapy knowledge with broad brand understanding, the synergies of which will provide clients with brand strategy for a fast-shifting clinical context."

The TPSi Oncology Business Unit was established when the company recognized that most of its clients were increasingly involved in oncology -- either marketing existing compounds or developing new compounds.  According to Sherry Fox, President, TPSi North America and founder of the unit, "We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who  would contribute the necessary expertise.  Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs."  

About THE PLANNING SHOP international

THE PLANNING SHOP international was established in 1987 as a strategic brand consultancy.  The company quickly expanded into market research and the pharmaceutical industry in particular, on which it now focuses 100% of its efforts.  The organization's unique brand-building market research products, delivered through branding and consultancy experience, makes TPSi unique in the pharmaceutical market research sector.  Constantly innovating by using new techniques, TPSi is committed to helping its clients build superior brands from Phase 2 to in-market.  With offices in London, Brussels, and Philadelphia, TPSi focuses on brand strategy in addition to market research, working on behalf of clients around the globe.  

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
3. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. Centage Corporation Announces Planning Maestro Business Performance Management Software for Mid-Market Enterprises
6. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
7. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
8. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
9. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
Post Your Comments:
(Date:10/12/2015)... SAN DIEGO , Oct. 12, 2015 /PRNewswire/ ... for debilitating allergic and inflammatory diseases and conditions, ... Series A preferred stock financing. Concurrent with the ... also entered into a Loan and Security Agreement ... borrow up to $7 million. Patara will use ...
(Date:10/12/2015)... Oct. 12, 2015 VolitionRx Limited (NYSE ... clinical study of its NuQ ® blood-based test for ... issue of Clinical Epigenetics , the official journal of ... collaboration with Lund University, ... MD, PhD, Professor of Surgery and Vice-Dean, Faculty of Medicine. ...
(Date:10/12/2015)... , ... October 12, 2015 , ... LifeTrak , ... launch of LifeTrak Zoom, the world’s first amphibious fitness tracker that seeks to meet ... flexwear technology and accurate heart rate monitoring both in water and on ...
(Date:10/10/2015)... 2015 Am 8. Oktober hat die ... für Kalifornien) ihre Würdigung der International Plasma Awareness ... Aufzeichnungen des Kongresses eintragen lassen. Die IPAW wird ... (PPTA) und ihren Mitgliedsunternehmen unterstützt. Ihre Ziele bestehen ... über Plasmaspenden weltweit , Würdigung des Beitrages ...
Breaking Biology Technology:
(Date:10/8/2015)... , 8. Oktober 2015 ... global tätiges Unternehmen des Bereiches Tracking, hat ... mit der Gefängnisbehörde Virginias (Department of Corrections ... elektronische Überwachungsdienste für alle Strafen geliefert werden, ... Cassell , Präsident für den Amerikanischen Kontinent ...
(Date:10/6/2015)... SAN MATEO, Calif. , Oct. 6, 2015 ... software company, today announced enhancements to its software ... gene expression analysis kit for differential expression in ... Analytic Platform, which is a cloud-based genomic analysis ... to advance scientific discovery from next-generation sequencing efforts. ...
(Date:9/30/2015)... 2015  The U.S. Court of Appeals for the ... in favor of Crossmatch ™, affirming the International ... Suprema and its U.S. partner Mentalix violated Section 337 ... that declares it unlawful to engage in "unfair practices" ... Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 patent. ...
Breaking Biology News(10 mins):